Robert Goulart to Risk Assessment
This is a "connection" page, showing publications Robert Goulart has written about Risk Assessment.
Connection Strength
0.018
-
Nayar R, Goulart RA, Tiscornia-Wasserman PG, Davey DD. Primary human papillomavirus screening for cervical cancer in the United States-US Food and Drug Administration approval, clinical trials, and where we are today. Cancer Cytopathol. 2014 Oct; 122(10):720-9.
Score: 0.018